Related Experiment Video
Updated: Aug 19, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Epidemiology of preterm birth and neonatal outcome
Shi Wu Wen1, Graeme Smith, Qiuying Yang
1OMNI Research Group, Department of Obstetrics & Gynecology, University of Ottawa, Ontario, Canada. swwen@ohri.ca
Insights
Preterm birth rates are rising, causing significant infant mortality and morbidity. While survival has improved, research must focus on reducing long-term complications and understanding preterm birth causes.
Area of Science:
- Neonatalogy
- Public Health
- Developmental Pediatrics
Background:
- Prevalence of preterm birth (<37 weeks' gestation) is increasing globally, affecting 5-11% of infants in industrialized nations.
- Preterm births are a leading cause of neonatal mortality (70%) and morbidity (75%), leading to long-term neurodevelopmental, pulmonary, and ophthalmologic issues.
- Advances in neonatal care, like antenatal corticosteroids and surfactant therapy, have improved survival but not reduced preterm birth incidence, incurring substantial healthcare costs.
Purpose of the Study:
- To highlight the increasing trend and severe consequences of preterm birth.
- To emphasize the need for research focused on preventing preterm births and mitigating long-term sequelae in survivors.
- To underscore the economic burden associated with caring for premature infants with complex health needs.
Main Methods:
- This abstract reviews existing data on preterm birth rates, mortality, morbidity, and associated healthcare costs.
- It synthesizes information on current interventions and their impact on survival versus prevention.
- It identifies key areas for future research based on current challenges and outcomes.
Main Results:
- Despite improved survival rates for extremely premature infants due to medical interventions, the incidence of preterm birth continues to rise.
- Current interventions primarily manage complications rather than prevent preterm birth itself.
- Significant societal and healthcare costs persist for the care of survivors with severe morbidities and developmental challenges.
Conclusions:
- Future research priorities should include elucidating the etiology and mechanisms of preterm birth.
- Focus is needed on developing strategies to reduce long-term health sequelae and developmental handicaps in preterm infants.
- A shift towards prevention and long-term outcome improvement is crucial for addressing the preterm birth crisis.
Abstract:
In industrialized countries, 5-11% of infants are born preterm (<37 weeks' gestation), and the rate has been increasing since the early 1980s. Preterm births account for 70% of neonatal deaths and up to 75% of neonatal morbidity, and contribute to long-term neurocognitive deficits, pulmonary dysfunction and ophthalmologic disorders. In the past several decades, major progress has been made in improving the survival of extremely premature newborns, mostly attributable to timely access to effective interventions that ameliorate prematurity-associated mortality and morbidity such as antenatal administration of corticosteroids and exogenous surfactant therapy, rather than preventing preterm births. However, the societal and healthcare costs to care for survivors with severe morbidity and neurological handicaps remain substantial. Future research should concentrate on the ways to reduce long-term health sequelae and developmental handicaps among survivors of infants born preterm, as well as elucidating the mechanisms and aetiology of preterm births.
Related Concept Videos
Development of the Oral Microbiota
Development of Human Microbiota
Teratogenicity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Regression Toward the Mean

